We report the case of a 67-year-old Japanese woman with diffuse large B-cell lymphoma who developed BK virus nephropathy (BKVN) following anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy. This evidence concerns the gene CD19 and BK-virus nephropathy.